A role for P selectin in complement-independent neutrophil-mediated glomerular injury  by Tipping, Peter G. et al.
Kidney international, Vol. 46 (1994), pp. 79—88
A role for P selectin in complement-independent neutrophil-
mediated glomerular injury
PETER G. TIPPING, XIA0 Ru HUANG, MICHAEL C. BERNDT, and STEPHEN R. HOLDSWORTH
Center for inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Centre, Clayton, and Baker Medical
Research institute, Prahran, Victoria, Australia
A role for P selectin in complement-independent neutrophil-mediated
glomerular injury. Neutrophil recruitment and lung injury following
complement activation have been demonstrated to be dependent on
endothelial expression of P selectin. In anti-glomerular basement mem-
brane antibody-induced glomerulonephritis (anti-GBM ON) in mice,
acute glomerular injury results from complement-independent neutro-
phil accumulation. The signals for neutrophil recruitment in this model
are unknown. Expression of P selectin on glomerular endotheium was
demonstrated within 30 minutes of administration of anti-GBM anti-
body to C57/BLIO mice. This was associated with rapid accumulation
of neutrophils in glomeruli which peaked at one hour (6.2 0.5
neutrophils per glomerular cross section [neut/gcs], normal 0.34 0.06
neut/gcs, P < 0.01) and significant proteinuria after 16 hours (3.6 0.5
mg/16 hr, control 0.62 0.13 mg/16 hr, P < 0.01). Complement
depletion with cobra venom factor, which reduced serum C3 levels to
less than 5% of normal, did not alter expression of P selectin, reduce
glomerular neutrophil accumulation (6.7 0.8 neut/gcs) or proteinuria
(3.7 0.5 mgIl6 hr). Platelet depletion also failed to alter glomerular
expression of P selectin, neutrophil accumulation or the development of
proteinuria. Mice were treated with an affinity purified anti-human P
selectin antibody, which cross reacted with mouse P selectin and
blocked P selectin-dependent binding of thrombin-activated mouse
platelets to HL6O cells and did not bind to mouse neutrophils. Treat-
ment, one hour prior to the administration of anti-GBM antibody,
markedly inhibited glomerular neutrophil accumulation (0.94 0.12
neutlgcs) and prevented proteinuria (1.0 0.2 mgII6 hr), and did not
alter binding of anti-GBM globulin in the kidney. These data strongly
suggest that the rapid up-regulation of P selectin expression in glomeruli
following binding of anti-GBM antibody is an essential signal for
neutrophil recruitment in this complement independent model of gb-
merular injury.
Neutrophil accumulation occurs rapidly in response to prod-
ucts of complement activation. Studies of acute neutrophil
mediated pulmonary injury induced in rats by administration of
cobra venom factor (CVF) have demonstrated an important role
for P selectin [1] and /32 integrins [2] in this process. The
contribution of 132 integrins to glomerular leukocyte recruitment
has recently been demonstrated in a complement dependent,
neutrophil mediated model of glomerulonephritis (ON) in rats
[3]. The role of P selectin in glomerular leukocyte recruitment
has not been investigated.
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Neutrophil transmigration across the endothelium involves a
complex series of events in which neutrophils first roll along the
endothelium and then are tethered more firmly prior to moving
between endothelial cells. The selectin molecules, particularly
P selectin, play a pivotal role in neutrophil rolling along the
endothelium [4], whereas /32 integrins appear to be critical for
the subsequent events [5].
In a number of forms of tissue injury in which neutrophil
transmigration across the endothelium occurs independent of
complement activation, a requirement for /32 integrins for
inflammatory cell recruitment has been demonstrated [6—9]. In
some models, however, anti-CD 18 antibodies which function-
ally block /32 integrin-mediated neutrophil/endothelial adhesion
do not prevent neutrophil recruitment [10, 11], suggesting that
other adhesion molecules are responsible for neutrophil local-
ization. In diseases where intraluminal accumulation of neutro-
phils results in injury without a requirement for endothelial cell
transmigration, P selectin may be essential for neutrophil re-
cruitment without any requirement for the /32 integrins. A
number of stimuli including thrombin, histamine, H202 and
terminal complement components have been demonstrated to
cause rapid surface expression of P selectin on endothelial cells
in vitro [12—16]. in vivo, however, up-regulation of endothelial P
selectin has only been demonstrated following complement
induced injury.
In mice, glomerular injury induced by heterologous anti-
glomerular basement membrane antibody (anti-GBM GN) oc-
curs following rapid neutrophil accumulation in glomerular
capillary loops [17, 18] which is complement independent.
Neutrophils mediate glomerular injury, possibly by production
of toxic oxygen radicals [19, 20] or by myeloperoxidase depen-
dent reactions [21], without the requirement for transmigration
across the glomerular endothelium. The signals for neutrophil
recruitment in this model are unknown. They do not involve
deposition of activated complement products along the glomer-
ular basement membrane (GBM) as classically described by
Cochrane, Unanue and Dixon [22]. Rapid translocation of P
selectin to the luminal surface of glomerular endothelial cells in
response to binding of immunoglobulin on the GBM may
provide the signal for neutrophil recruitment in this situation.
This hypothesis was tested by studying the expression of P
selectin in glomeruli of mice developing anti-GBM GN, and by
in vivo inhibition of P selectin using a functionally inhibitory,
affinity-purified anti-P selectin antibody.
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Methods
Animals
Male C57/BL1O mice at six to eight weeks of age were
obtained from Monash University, Central Animal Services,
Clayton, Victoria, Australia.
Production and characterization of sheep anti-mouse anti-
GBM globulin
Anti-GBM globulin was raised in a sheep by repeated immu-
nization with a membrane fraction of mouse kidney in Freunds
complete adjuvant (FCA, Sigma Chemical Co., St. Louis,
Missouri, USA). The sheep serum was heat decomplemented
and absorbed twice against mouse red blood cells (10% by
volume). A globulin fraction was prepared by precipitation with
ammonium sulphate at a final concentration of 50%and was
extensively dialyzed against phosphate buffered saline (PBS).
When administered intravenously to naive mice, this anti-GBM
globulin induced immediate dose dependent proteinuria at
doses exceeding 250 pg/g body weight. By indirect immunoflu-
orescence microscopy using a fluorescein conjugated rabbit
anti-sheep globulin (Dako, Glostrup, Denmark), sheep globulin
was demonstrated to bind to mouse glomeruli in a linear pattern
without detectable binding to other renal structures.
Assessment of glomerular neutrophil accumulation
Renal tissue sections (2 p.m thickness) were cut from paraffin
embedded tissue fixed in Bouins fixative, and stained with
periodic acid Schiff (PAS) reagent. Neutrophils, identified by
their typical polymorphonuclear appearance, were counted in
glomeruli cut in equatorial section. A minimum of 20 glomeruli
from each animal were counted to give a mean glomerular
neutrophil count.
Quantitation of proteinuria
Mice were housed in metabolic cages to collect urine over a
16 hour period. The urine volume was estimated by weight.
Urinary protein concentrations were measured in a microtiter
plate assay by the dye binding method described by Bradford
[231. Light absorbance (595 nm wavelength) was measured in an
ELISA plate reader (Dynatech MR7000, Dynatech, Chantilly,
Virginia, USA), 10 minutes after addition of Coomassie blue
reagent (100 pg/mI Electran Page Blue G90; BDH Chemicals,
Poole, UK, 5% ethanoll8.l% orthophosphoric acid) to urine
samples. Protein concentrations were calculated by reference
to standard concentrations of bovine serum albumin (BSA,
Sigma Chemical).
Quantitation of binding of anti-GBM globulin
Sheep anti-mouse GBM globulin was labeled with 125Jby the
chioramine T method and extensively dialyzed against PBS.
Trace labeled globulin was administered intravenously at a dose
of 500 zg/g body weight. Mice were killed 16 hours later, and
the kidney placed in PBS at 4°C. Kidney tissue was homoge-
nized and then centrifuged at 3000 rpm for 20 minutes and the
pellet washed six times in PBS at 4°C, and counted for 125!
activity in a gamma counter (LKB Wallac, Turku, Finland).
The binding of anti-GBM globulin was determined from the
specific activity of the injected globulin and expressed per gram
wet weight of kidney tissue.
Production and characterization of anti-P selectin antibody
Affinity-purified polyclonal anti-human P selectin antibody
was raised and characterized as previously described [24, 251.
By Western blot analysis, the reactivity of this antibody to
mouse platelets was similar to its reactivity to human platelet
proteins [25]. Fab fragments were prepared by papain digestion
as previously described [24]. These fragments were shown to
inhibit calcium dependent binding of thrombin-activated mouse
platelets to HL6O cells. P selectin-mediated binding was as-
sessed in vitro by rosetting with HL6O cells according to the
method of Larsen et al [26]. Activated and nonactivated plate-
lets were incubated with 5 m EDTA, anti-P selectin Fab (30
p.g/ml) or non-immune rabbit Fab fragments (30 pg/mi) for 20
minutes at 21°C, and then with HL6O cells under similar
conditions on an orbital mixer. The percentage of cells forming
rosettes with  3 platelets/cell was determined after counting
100 cells using a hemocytometer.
Binding of P selectin antibody to mouse neutrophils was
assessed by fluorescence-activated cell sorting (FACS). Mice
were injected with 500 U of sodium heparin intravenously and
were bled five minutes later. Blood was centrifuged at 200 x g
for 10 minutes and the cells washed twice with PBS containing
1% fetal calf serum and 0.01% sodium azide. Red blood cells
were lysed by treatment with 0.1% formic acid (Coulter Elec-
tronics, Hialeah, Florida, USA). Leukocytes were washed,
centrifuged and incubated with anti-P selectin antibody at a final
concentration of 50 pg/mI for 15 minutes at room temperature.
Incubation with normal rabbit immunoglobulin (50 pg/mI) was
performed as a negative control. Binding of rabbit immunoglob-
ulin was detected using FITC conjugated sheep anti-rabbit
immunoglobulin serum (Silenus, Hawthorn, Victoria, Austra-
ha) by FACS (EPICS 752, Coulter), with gating to assess
mononuclear and neutrophil populations. Staining for Mac-i
(CD1 Ib) using a monoclonal rat anti-murine antibody (M1170,
Caltag Laboratories, San Francisco, California, USA) and
FITC conjugated sheep anti-rat immunoglobulin serum (Sile-
nus) served as a positive control.
Demonstration of P selectin on glomerular endothelium
Renal tissue from normal mice and mice injected with anti-
GBM globulin was fixed in periodate-lysine-paraformaldehyde
(PLP, Ajax Chemicals, Sydney, Australia) for four hours at 4°C
and washed in 7% sucrose/PBS for 36 hours, embedded in OCT
compound (Tissuetek, Miles, Elkhart, Indiana, USA) and fro-
zen in liquid nitrogen cooled isopentane. Cryostat cut tissue
sections (4 p.m thickness) were stained using a three layer
immunoperoxidase technique to demonstrate P selectin. The
primary antibody was rabbit anti-P selectin antibody (50 pg/mi).
Non-immune rabbit immunoglobulin substituted as a control for
non-specific staining. This was followed by peroxidase-conju-
gated swine anti-rabbit IgG (Dako) at a dilution of 1 in 50, then
peroxidase conjugated rabbit anti-peroxidase globulin (Dako) at
a dilution of 1 in 100. Sections were then incubated with
diaminobenzidine at 100 pg/mi for five minutes and counter-
stained with Harris hematoxylin (Gurr BDH Chemicals, Poole,
UK) for one minute. Expression of P selectin in glomeruli was
graded semiquantitatively. No P selectin staining in any glomer-
ulus was graded as 0. Positive staining in some glomeruhi was
graded +1—. Animals with staining in all glomeruli were graded
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+ to + + + according to the intensity of staining. The maximum
intensity of staining observed was graded + + +.
In vivo complement depletion
Purified cobra venom factor (CVF) was prepared from cobra
venom (Naja, naja; Sigma Chemical) by ion exchange chroma-
tography as described by Ballow and Cochrane [27]. Mice
received three intraperitoneal injections of a total of 2 ml of
purified CVF over 24 hours, prior to initiation of GN. Serum C3
levels were measured by radial immunodiffusion in an agarose
gel containing goat anti-mouse C3 antiserum (Cappel, Durham,
North Carolina, USA) at a concentration of 5 p,g/ml. Pooled
normal mouse serum at dilutions from neat to 1 in 64 was run in
duplicate to construct a standard curve of the diameter of the
precipitin ring against the C3 concentration. Serum from CVF
treated mice was also run in duplicate, and the mean diameter
of the precipitin ring was used to determine the C3 concentra-
tion relative to normal mouse serum. All CVF treated mice had
serum C3 concentrations of less than 5% of normal in this
assay.
In vivo platelet depletion
Platelet depletion was induced by a polyclonal rabbit anti-
mouse platelet antibody which recognizes the platelet Jib-lila
glycoprotein [28] (a gift of Dr. M.V. Berridge, Wellington, New
Zealand). This antibody was heat decomplemented and ab-
sorbed against mouse red blood cells, and was administered at
a dose of 50 jsllmouse intravenously. Platelet counts were
measured on an automated hematology counter (Sysmex
K-bOO, Toa Medical Counter, Kobe, Japan). This antibody
produced severe platelet depletion (18 3 x i0 jd', N = 6)
in C57/BL1O mice (normal 1061 29 x io sl', N = 6) four
hours after administration. Anti-selectin antibody given at a
dose of 2.5 gIg, i.v. produced only minor platelet depletion
(after 1 hr, 823 82 X i03 p11, N = 4; after 16 hr, 681 103
x l0 p11, N = 4).
Circulating neutrophil counts
Mouse blood was collected into EDTA, and total white cell
numbers were counted on using a hemocytometer after dilution
and lysis of red blood cells in diluting chambers containing
ammonium oxalate (Unopette, Becton-Dickinson, Rutherford,
New Jersey, USA). A differential white cell count was obtained
for each mouse by counting 200 nucleated cells on a blood
smear stained with Wright/Giemsa stain. Neutrophils were
identified by their typical nuclear morphology. Circulating
neutrophil numbers were calculated from the total white cell
count by allowing for the percentage of neutrophils.
Experimental protocol
Urine was collected for 16 hours, immediately prior to
initiation of any experimental protocols, to determine baseline
urinary protein excretion. Anti-GBM GN was induced in mice
by a single intravenous injection of 500 g/g sheep anti-mouse
GBM globulin. The following groups were studied: (1.) normal
mice given anti-GBM globulin were killed after 15 minutes (N =
3), 30 minutes (N = 3), one hour (N = 6), two and four hours (N
= 3 per time point) and 16 hours (N = 6) to assess the timing of
the neutrophil influx. (2.) Complement depleted mice given
anti-GBM globulin. (3.) Platelet depleted mice given anti-GBM
I I
Thrombin activated platelets
Fig. 1. Functional characterization of affinity-purified anti-P selectin
antibody, by its capacity to inhibit Ca2 dependent binding of throm-
bin-activated mouse platelets to HL6O cells. The Fab fragments were
tested at a final concentration of 30 p.s/mt and EDTA at 5 m. Results
illustrate a representative experiment.
globulin. (4.) Mice pretreated with anti-P selectin antibody (2.5
p.glg, i.v.), one hour prior to anti-GBM globulin. (5.) Mice
pretreated with protein G purified rabbit immunoglobulin (2.5
tg/g, i.v.), one hour prior to anti-GBM globulin. In Groups 2, 3,
4, and 5, renal histology was assessed after one hour (N =6 per
group) and 16 hours (N 6, except in group 3 where N = 4).
Proteinuria was assessed over 16 hours in each group. Renal
histology in mice treated with CVF (Group 2) was also assessed
prior to administration of anti-GBM globulin (N = 2).
In vitro studies of P selectin expression by endothelial cells
exposed to anti-GBM globulin
To determine whether anti-GBM globulin can directly up-
regulate P selectin expression, studies were performed on
human umbilical endothelial cells (HUVEC's) in vitro. Early
passage HUVEC's were seeded in 12 mm diameter, gelatin-
coated tissue culture wells (Costar, Cambridge, Massachusetts,
USA) and grown to confluence (approximately 1 x io cells!
well) in M199 medium containing 20% fetal calf serum (Com-
monwealth Serum Laboratories, Parkville, Victoria, Australia),
heparin (5 U/mi) and endothelial cell growth supplement (5
mg/mi). Sheep anti-mouse GBM globulin at final concentrations
of 2 mg/mi, 200 gIml, and 20 g/ml or normal sheep globulin (2
mglml) was then added for one hour, and P selectin expression
by HUVECS was analyzed on by FACS using the staining
protocol previously described for neutrophils.
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Fig. 2. Photomicrographs of mouse glomeruli demonstrating normal histological appearance (A, PAS stain) and the immunopathological
features of anti-GBM GN, including linear deposition of heterologous globulin on the GBM (B, immunofluorescence using rabbit anti-sheep
globulin FITC), numerous neutrophils with glomerular capillary loops (C, PAS stain), and sparse complement deposition (D, indirect
immunofluorescence using goat anti-mouse (C3). (Magnification x 400).
Statistical analysis Results
Results are expressed as the mean and standard error of the Characterization of the reactivity of anti-human P selectin
mean (sEM) for each group. Statistical analysis was performed antibody with mouse P selectin
using the Student's f-test for unpaired data. P values are
indicated where differences are statistically significant. Where Western blot analysis of human and mouse platelets indicated
P values are > 0.05, NS is used to denote lack of statistical that the affinity-purified rabbit anti-P selectin antibody cross
significance between results, reacted with mouse P selectin and did not cross react with other
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Fig. 3. The timing of glomerular neutrophil accumulation and expres-
sion of P selectin during the development of anti-GBM GN.
mouse platelet or endothelial cell proteins, including E selectin
[29]. This antibody has been previously shown to completely
block the calcium-dependent binding of purified human P
selectin to HL6O cells and the rosetting of HL6O cells by
thrombin-activated human platelets [24]. The data in Figure 1
establish that this antibody similarly blocks mouse P selectin
adhesive function as judged by its effect on the rosetting of
HL6O cells by thrombin-activated mouse platelets. Anti-P Se-
lectin antibody did not bind to mouse neutrophils. By FACS
analysis, 2.5% of neutrophils were positive using the anti-P
selectin antibody, compared with 1.8% with normal sheep
immunoglobulin and 94% using anti-Mac-I antibody.
Characterization of anti-GBM GN
Anti-GBM globulin bound rapidly to the GBM, producing a
typical linear staining pattern (Fig. 2B) and a proliferative GN
with prominent neutrophil accumulation (Fig. 2C) which was
not seen in normal mouse glomeruli (Fig. 2A). Only scattered
sparse staining for C3 was demonstrated in glomeruli (Fig. 2D).
Anti-GBM globulin induced significant proteinuria after 16
hours (3.6 0.5 mg/16 hr, baseline 0.62 0.13 mgll6 hr; P <
0.001). Glomerular neutrophil accumulation was increased after
15 minutes (0.76 0.10) and 30 minutes (1.7 0.1 neut/gcs),
and was maximal after one hour (6.2 0.5 neutlgcs; normal,
0.34 0.06 neut/gcs, P < 0.001). At subsequent times, glomer-
ular neutrophil numbers progressively declined, (2 hr, 3.6 0.6
neutlgcs,4hr; 1.8 O.Sneutfgcs; 16 hr 2.1 0.2 neut/cgs) (Fig.
3) but remained significantly greater than normal (P < 0.001 at
each time point).
Expression of P selectin in anti-GBM GN
P selectin was undetectable in normal mouse glomeruli by
immunohistochemistry (Fig. 4A). After administration of anti-
GBM globulin, expression of P selectin was variably observed
in glomeruli at 15 minutes (Fig. 4B). After 30 minutes, all
glomeruli in each animal demonstrated positive staining for P
selectin. P selectin staining was maximal at one hour (Fig. 4C)
and two hours, and at later times appeared to decline slightly
(16 hr, Fig. 4D). Staining was not observed in diseased glomer-
uli when normal rabbit globulin was substituted for rabbit anti-P
selectin antibody in the immunoperoxidase protocol, demon-
strating the lack of significant cross reactivity of the secondary
antibodies with the deposited anti-GBM globulin. The earliest
expression of P selectin appeared segmented in distribution, but
after one hour staining for P selectin was observed around
capillary lumens throughout the glomerulus (Fig. 5).
Effect of complement depletion on anti-GBM GN
Effect of platelet depletion on anti-GBM GN
Anti-platelet serum reduced circulating platelet numbers by
98% at the time of administration of anti-GBM globulin. One
hour after anti-GBM globulin, platelets remained profoundly
depleted (15 1 x l0 l', normal 1061 29 x io jxl, P <
0.0001); however, glomerular neutrophil accumulation (5.8
0.3 neut/gcs) was unaffected compared to untreated disease
(NS; Table 1). Expression of P selectin in glomeruli was also
unaltered at this time (data not shown). After 16 hours, circu-
lating platelet remained depleted (13 1 x 103 1.d1, P < 0.0001
compared to normal mice) but proteinuria (3.0 0.6 mg!16 hr
baseline 0.54 0.14 mgll6 hr; Fig. 6) and glomerular neutrophil
accumulation (1.3 0.2 neut/gcs) were both unaffected (both
NS compared to normal mice developing anti-GBM GN) (Table
2). Expression of P selectin in glomeruli remained prominent.
Effect of anti-P selectin antibody on development of
anti-GBM GN
Pretreatment with anti-P selectin antibody prevented the
development of proteinuria (1.0 0.2 mgll6 hr; baseline 0.96
0.13 mgIl6 hr; NS). Glomeruli did not exhibit a proliferative
pattern (Fig. 7A). Although there was a small increase in
glomerular neutrophils at one hour (0.94 0.12 neutlgcs), they
were significantly reduced (to less than 8%) compared to the
neutrophil influx associated with untreated disease (P < 0.001).
After 16 hours, glomerular neutrophil numbers declined to 0.68
0.10 neut/gcs, but remained significantly greater than normal
(P < 0.001; Table 1). The increase in neutrophils in glomeruli of
anti-P selectin treated mice (1 hr, x 2.8-fold; 16 hr, x 2-fold
neutrophil numbers in normal glomeruli) was similar to the
increase in circulating neutrophils at these time points (I hr, x
2.5-fold; 16 hr x 2.2-fold of normal circulating neutrophil
numbers). Treatment of mice developing anti-GBM GN with
protein G-purified normal rabbit immunoglobulin did not affect
the histological apperances of GN (Fig. 7B), proteinuria (3.5
0.6 mg/l6 hr, baseline 0.71 0.29 mg!l6 hr; Fig. 6) or peak
glomerular neutrophil influx (6.8 0.7 neut/gcs at 1 hr) (all
values ns compared to the results for untreated mice developing
anti-GBM GN; Table 1). Anti-P selectin antibody did not alter
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Proteinuria in complement deplete mice (3.7 0.5 mg/16 hr,
baseline 0.53 0.13 mgIl6 hr) was not different to complement
intact mice (NS; Fig. 6). The timing and extent of the peak
glomerular neutrophil influx was unaltered (at 1 hr, 6.7 0.8
neut/cgs; and 16 hr, 1.7 0.3 neut/cgs; NS) compared to
complement intact mice (Table 1). C3 was not detectable in
glomeruli by indirect immunofluorescence microscopy, and
expression of P selectin in glomeruli was undetectable after
treatment with CVF, prior to administration of anti-GBM
globulin.
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Fig. 4. Expression ofF selectin in a normal mouse glomerulus (A) and in glomeruli during the development of anti-GBM GN at 15 minutes (B),
1 hour (C) and 16 hours (D). (Immunoperoxidase; magnification x 400).
the glomerular deposition of sheep anti-GBM globulin (assessed
by immunofluorescence) or its renal binding (anti-P selectin
treated, 205 15 g kidney fixed globulin/g wet weight of
kidney; normal rabbit Ig treated, 210 25 g kidney fixed
globulin/g wet weight of kidney; NS).
Effect of anti-P selectin on circulating neutrophils
Development of anti-GBM ON was associated with a pro-
gressive neutrophilia (Table 2). Normal circulating neutrophil
numbers (1194 94 jil) increased significantly to 3097 458
1.d1 after one hour (P < 0.001) and 4494 691 d' at 16 hours
(P < 0.001). Decomplemented mice showed a similar neutro-
philia (2458 250 p.11 at 1 hr, 4030 427 /.Ll at 16 hr).
Treatment with anti-P selectin antibody did not reduce the
neutrophilia observed at one hour (3142 202 l') but
reduced the neutrophilia at 16 hours (2603 383 pJ 'P < 0.05
compared to untreated mice with anti-GBM GN). Normal
Fig. 5. Demonstration of the distribution of P selectin around capillary rabbit immunoglobulin did not alter the development of neutro-
loops of a glomerulus, 1 hour after administration of anti-GBM philia (2990 125 jd ' at 1 hr; 4025 266 p1 ' at 16 hrs; NS
antibody. (Immunoperoxidase; magnification x 1000). compared to untreated mice).
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Fig. 6. Baseline proteinuria (hatched bars) and proteinuria following
anti-GBM globulin in mice after treatment with anti-P selectin antibody
or non-immune rabbit immuno globulin and after complement depletion
or platelet depletion. * Significant increase (P < 0.01) compared to
baseline proteinuria. Anti-P selectin antibody treated mice did not
develop significant proteinuria.
Effect of anti-GBM globulin on in vitro expression of
P selectin by HUVECs
P selectin expression was detectable on 6.8% of cultured
HUVECs under basal conditions. P selectin expression was not
affected by incubation with anti-GBM globulin (2 mg/mi, 5.9%
positive; 200 g/ml, 7.3% positive; 20 /LgIml, 7.8% positive) or
normal sheep globulin (2 mg/mi, 5.9% positive).
Discussion
Binding of heterologous immunoglobulin to the GBM results
in rapid recruitment of neutrophils and glomerular injury.
Neutrophils which accumulate in glomerular loops are in close
contact with the endothelium. Infiltrating neutrophils are acti-
vated, releasing lysosomal enzymes [21] and reactive oxygen
species [19, 20], thereby damaging the glomerular filtration
barrier, resulting in proteinuria and a fall in glomerular filtration
rate. In some areas they appear to strip endothelial cells away
from the basement membrane [22]; however, in general they do
not transmigrate across the endothelium or the basement mem-
brane. In mice, only sparse deposition of complement is ob-
served in glomeruli [17]. Systemic complement depletion using
CVF and genetic complement deficiency does not attenuate
glomerular neutrophils recruitment or injury [17, 18], suggesting
that activation products of complement are not essential in this
disease.
The signals responsible for neutrophil recruitment in this
situation are unknown. The rapidity of the process suggests a
role for P selectin. Although a number of stimuli can augment
expression of P selectin on endothelial cells in vitro, the
capacity of factors other than complement to up-regulate P
Glomerular neutrophil accumulation
neut/gcs
1 hour 16 hour
Untreated anti-GBM GN 6.2 0.5 2.1 0.2
Decomplemented 6.7 0.8 1.7 0.3
Platelet depleted 5.8 0.3 1.3 0.2 (N = 4)
Anti-P selectin treated 0.94 0.12a 0.68 0.lOa
Control antibody treated 6.8 0.7 1.5 0.2
Results indicate mean SEM, N = in each group except where
indicated otherwise. Glomerular neutrophil numbers in normal mice
were 0.34 0.06 neutigcs.
a Significantly reduced (P < 0.01) compared to untreated anti-GBM
ON
Blood neutrophils cells/p.!
1 hour 16 hour
Untreated anti-GBM ON
Decomplemented
Anti-P selectin treated
Control antibody treated
3097 458
2458 250
3142 202
2990 125
4494 691
4030 427
2603 383k
4025 266
selectin on vascular endothelium and recruit neutrophils has not
been demonstrated in vivo. Rapid expression of P selectin in
glomeruli was observed after administration of heterologous
anti-GBM globulin. Expression of P selectin was unaffected by
platelet depletion, indicating that it was not due to local platelet
aggregation and activation. P selectin was detectable after 15
minutes on endothelial cells in glomerular capillary loops in
occasional glomeruli. At this time, neutrophil accumulation was
first observed. Intense expression of P selectin was present on
capillary loops in all glomeruli after one hour. The timing of
expression of P selectin showed close correlation with the
appearance of neutrophils in glomeruli which also peaked at one
hour. Like glomerular neutrophil accumulation in this model,
expression of P selectin was unaffected by complement deple-
tion. The binding of neutrophils to P selectin may facilitate their
local activation, particularly if endothelial cell platelet activat-
ing factor is co-expressed [30].
The rapid expression of P selectin in glomeruli is consistent
with the observation that P selectin is rapidly redistributed from
cytoplasmic stores in Weibel Palade bodies to the endothelial
surface during cellular activation [12-44], and is consistent with
the report of Mulligan et al [1] that P selectin in Weibel Palade
bodies is not immunohistochemically detectable. In addition, it
confirms the capacity of the microvascular endothelium of the
glomerulus to express P selectin upon activation. The onset of
this process in glomeruli corresponds with antibody deposition
along the GBM suggesting that this is the initiating event. P
selectin was not observed on the endothelium of intra-renal
vessels, in which antibody was not deposited, and anti-GBM
globulin did not directly induce expression of P selectin on
ii Table 1. Glomerular neutrophil accumulation after anti-GBMglobulin54
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Table 2. Circulating neutrophils after anti-GBM globulin
Results indicate mean SEM, N = 6 for each group. Circulating
neutrophils numbers in normal mice were 1194 94 cells/sl.
a Significantly reduced (P < 0.05) compared to untreated anti-OBM
GN at 16 hours
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Fig. 7. Histological features of GN in mice developing anti-GBM GN, treated with anti-P selectin immunoglobulin (A) and non-immune rabbit
immunoglobulin (B). (PAS stain; magnification x 400).
cultured endothelial cells, indicating that antibody binding to
the GBM is required for induction of P selectin expression.
One hour after administration of anti-GBM globulin, neutro-
phil numbers in glomeruli declined, despite more delayed and
less marked decline in expression of P selectin. There are a
number of potential explanations for this observation. These
would include functional inactivation of P selectin by neutrophil
proteolytic enzymes without destruction of all the antigenic
epitopes, or cleavage of P selectin from the endothelial cell
surface, with local phagocytosis. The pool of neutrophils which
are released and contribute to the neutrophilia may have a
lower functional capacity to bind P selectin, or competition
from P selectin shed from damaged endothelial cells may inhibit
their binding to the endothelium.
Persistent expression of P selectin associated with increased
mRNA and protein synthesis has been demonstrated following
endothelial cell activation with tumor necrosis factor [31] and
has also been demonstrated on microvascular endothelium in
the brain, 24 hours after ischemia reperfusion injury [32].
Release of other neutrophil products including reactive oxygen
species may also augment or perpetuate P selectin expression of
endothelial cells [15]. It is unlikely that the expression of P
selectin at later time intervals is platelet associated as this was
unaffected by severe platelet depletion.
In vivo administration of anti-P selectin antibody demon-
strated a pivotal functional role for P selectin in glomerular
neutrophil accumulation. This affinity purified antibody was
raised against human P selectin and identifies a single band on
Western blot analysis of platelet proteins [25]. It inhibited Ca2
dependent binding of thrombin-activated mouse platelets to
HL6O cells, indicating that it also functionally blocks mouse P
selectin. Administration of anti-P selectin antibody to mice one
hour prior to anti-GBM antibody significantly reduced glomer-
ular neutrophil accumulation. The peak increase in neutrophils
observed at one hour was reduced by greater than 90%. The
small net increase in glomerular neutrophils in anti-P selectin
antibody-treated mice was of the same order as the increase in
circulating neutrophils, both at 1 hour and 16 hours, suggesting
that this may be solely a reflection of the blood neutrophilia and
not due to specific glomerular adhesion. Abrogation of glomer-
ular neutrophil accumulation prevented development of pro-
teinuria confirming that injury in this model is neutrophil
mediated. Treatment with anti-P selectin antibody did not
reduce binding of anti-GBM antibody, or reduce the neutro-
phiia which was observed one hour after administration of
heterlogous globulin, however, it did prevent the persistence of
this neutrophilia observed at 16 hours in untreated mice. This
suggests that the early neutrophilia is an acute effect from the
heterologous globulin, whereas the later neutrophiia is at least
partially a response to the glomerular inflammation.
In vitro, P selectin has been demonstrated to play an impor-
tant role in neutrophil adhesion to activated endothelium [33].
In vivo, a requirement for P selectin, has been demonstrated in
leukocyte adhesion to platelets in a dacron vascular graft [34]
and in complement induced, neutrophil-mediated pulmonary
injury [1]. Lung neutrophil accumulation, assessed indirectly by
myeloperoxidase content, was reduced by 50% using maximally
effective doses of anti-P selectin antibody, and injury was
reduced by 70%. This suggests other adhesion molecules may
also be involved in neutrophil recruitment in this model. In
acute anti-GBM GN in rats, a model in which glomerular
neutrophil recruitment and injury is complement dependent,
attentuation of injury by blocking lymphocyte function associ-
ated antigen-i and intercellular adhesion molecule-i (ICAM-i)
has recently been demonstrated [3]. In more chronic and
complex models of GN, for example crescentic GN, which
require migration of inflammatory cells across the endothelium
into the mesangium and Bowmans space, requirements for
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lymphocyte function associated antigen-i and ICAM-1 were
also anticipated and demonstrated [35, 36].
A role for P selectin has not previously been demonstrated in
glomerular injury, although the involvement of other adhesion
molecules is being actively investigated [reviewed in 37—39]. In
the current studies, P selectin was shown to be rapidly up-
regulated in glomeruli following binding of anti-GBM globulin,
and glomerular injury was totally prevented by an anti-P
selectin antibody. This suggests a pivotal role for P selectin in
neutrophil recruitment in this disease. These observations
provide an explanation for the rapid complement-independent
glomerular neutrophil recruitment observed in acute murine
anti-GBM GN.
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Appendix. Abbreviations
anti-glomerular basement membrane anti-
body-initiated glomerulonephritis
cobra venom factor
glomerular basement membrane
glomerulonephritis
intercellular adhesion molecule-i
neutrophils per equatorial glomerular cross
section
periodic acid Schiff reagent
phosphate buffered saline
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